Moleculin Biotech Inc: Recruitment Increased to 22 Subjects and Crc's in All Subjects Evaluable for Efficacy (N=20) Was 45% in Study
Moleculin Biotech Inc:招募人數增加至22人,所有可評估療效的CRC人數(N=20)在該研究中爲45%。
Moleculin Biotech Inc: Recruitment Increased to 22 Subjects and Crc's in All Subjects Evaluable for Efficacy (N=20) Was 45% in Study
Moleculin Biotech Inc:招募人數增加至22人,所有可評估療效的CRC人數(N=20)在該研究中爲45%。
譯文內容由第三人軟體翻譯。